Plus Therapeutics Inc (PSTV)

Finanzdaten der Plus Therapeutics Inc-Aktie (PSTV)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	27.72% 1.677	1.313	1.24	1.854	0.506
Operating Expenses	3.81% 4.976	5.173	4.491	3.344	5.226
Interest Income/Expense	45.16% 0.034	0.062	0.087	0.112	0.134
Benefits Costs and Expenses	3.61% 4.938	5.123	4.459	3.336	5.311
Costs And Expenses	3.81% 4.976	5.173	4.491	3.344	5.226
Operating Income/Loss	14.53% -3.299	-3.86	-3.251	-1.49	-4.72
Nonoperating Income/Loss	24.00% 0.038	0.05	0.032	0.008	-0.085
Income/Loss From Continuing Operations Before Tax	14.41% -3.261	-3.81	-3.219	-1.482	-4.805
Income/Loss From Continuing Operations After Tax	14.41% -3.261	-3.81	-3.219	-1.482	-4.805
Net Income/Loss	14.41% -3.261	-3.81	-3.219	-1.482	-4.805
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	854.67% 4.3217	0.4527	3.2254	2.5094	34.80
Diluted Average Shares	854.67% 4.3217	0.4527	3.2254	2.5094	34.80
Basic Earnings Per Share	7.14% -0.75	-0.70	-1.00	-0.59	-0.14
Diluted Earnings Per Share	7.14% -0.75	-0.70	-1.00	-0.59	-0.14
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-